FddA demonstrates anti-HIV activity at well-tolerated doses in phase I trial Feb. 5, 1998 No Comments
PNU-140690: clinical pharmacokinetics and safety after single and multiple doses Feb. 5, 1998 No Comments
Favorable clinical safety, pharmacokinetics and anti-CMV activity reported for 1263W94 Feb. 5, 1998 No Comments
RSS